作者：
Morgan,A.R. [1]
;
Parker,G.J.M. [2]
;
Roberts,C. [3]
;
Buonaccorsi,G.A. [4]
;
Maguire,N.C. [5]
;
HubbardCristinacce,P.L. [6]
;
Singh,D. [7]
;
Vestbo,J. ;
Bjermer,L. ;
J?gi,J. ;
Taib,Z. ;
Sarv,J. ;
Bruijnzeel,P.L.B. ;
Olsson,L.E. ;
Bondesson,E. ;
Nihlén,U. ;
McGrath,D.M. ;
Young,S.S. ;
Waterton,J.C. ;
Nordenmark,L.H.
作者单位：
University of Manchester, Medicines Evaluation Unit, University Hospital of South
[1]
AstraZeneca R and DM?lndal, Sweden
[2]
Department of Clinical Physiology, Ska?ne University Hospital, Lund UniversityLund, Sweden
[3]
AstraZeneca R and D, Alderley Park, United Kingdom
[4]
Bioxydyn Ltd., Rutherford House, Pencroft Way, Manchester Science ParkManchester, United Kingdom
[5]
Centre for Imaging Sciences and Biomedical Imaging Institute, Manchester Academic Health Sciences
[6]
Department of Respiratory Medicine and Allergology, Ska?ne University HospitalLund, Sweden
[7]
发布时间
2015-02-11
换一批
